Technicals for Jubilant Pharmova Limited
The PSAR's reversal from bearish to bullish suggests a possible trend change....
More about Jubilant Pharmova Limited
Fundamentals for Jubilant Pharmova Limited
JUBLPHARMA's Forward PE ratio is in a good range, reflecting a reasonable...
Regulatory Filings for Jubilant Pharmova Limited
The list of all important regulatory filings for Jubilant Pharmova Limited which...
Expense Surge or Growth Engine? Investor Implications of JPMorgan's 2026 Spending Plan
An analysis of JPMorgan Chase's $105 billion 2026 expense guidance, exploring its...
Corporate Leaders Double Down on AI, Talent and Customer Personalisation
An investor-oriented article synthesising corporate leaders’ optimism for 2025 and the top...
Financial Services in Flux: Debanking, Cost Pressures and the Rise of Crypto Prediction Markets
An investor-focused analysis of major shifts in the financial services landscape as...
Regulatory Filings for Jubilant Pharmova Limited
Recent filings by Jubilant Pharmova Limited
| Published | Title | Summary |
|---|---|---|
| 2025-01-23 11:23:50 | Board Meeting Intimation | JUBILANT PHARMOVA LIMITED has informed the Exchange about Board Meeting... |
| 2024-10-17 18:26:49 | Board Meeting Intimation | JUBILANT PHARMOVA LIMITED has informed the Exchange about Board Meeting... |
| 2024-10-04 21:53:19 | Acquisition-XBRL | JUBILANT PHARMOVA LIMITED has informed the Exchange regarding Acquisition... |
| 2024-10-04 17:51:00 | Acquisition | Jubilant Pharmova Limited has informed the Exchange about Acquisition... |
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Lists of companies in NSE500 with the best and the worst fundamentals...
Latest Regulatory Filings for NSE500
List of the latest important filings for NSE500....
Companies with the best and the worst technicals.
Lists of companies in NSE500 with the best and the worst technicals...
Tariffs, Trade Disruption, and the Rise of Resilient Supply Chain Models
An article analysing how new U.S. tariff policies are contributing to economic...
The Oracle Paradox: AI Backlog Boom Meets Revenue Miss
An article exploring Oracle’s latest quarterly results that reveal a significant AI...
From Rate Cuts to Asset Purchases: Decoding the Fed’s 2025 Finale for the 2026 Outlook
An in-depth article analysing the Federal Reserve’s December 2025 rate cut and...